These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10727131)

  • 1. A sensitive LC-MS/MS method for the quantification of fluticasone propionate in human plasma.
    Krishnaswami S; Möllmann H; Derendorf H; Hochhaus G
    J Pharm Biomed Anal; 2000 Feb; 22(1):123-9. PubMed ID: 10727131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An improved method for the determination of fluticasone propionate in human plasma.
    Laugher L; Noctor TG; Barrow A; Oxford JM; Phillips T
    J Pharm Biomed Anal; 1999 Dec; 21(4):749-58. PubMed ID: 10701940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sensitive method for the quantification of fluticasone propionate in human plasma by high-performance liquid chromatography/atmospheric pressure chemical ionisation mass spectrometry.
    Li YN; Tattam BN; Brown KF; Seale JP
    J Pharm Biomed Anal; 1997 Nov; 16(3):447-52. PubMed ID: 9589403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive liquid chromatography-tandem mass spectrometry method for the quantification of mometasone furoate in human plasma.
    Sahasranaman S; Tang Y; Biniasz D; Hochhaus G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(1):175-9. PubMed ID: 15797536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous analysis of glucocorticosteroid fluticasone propionate and its metabolite fluticasone propionate 17β-carboxylic acid in human plasma by UPLC-MS/MS at sub pg/mL level.
    Nair SG; Patel DP; Sanyal M; Singhal P; Shrivastav PS
    J Pharm Biomed Anal; 2017 Feb; 135():1-7. PubMed ID: 27987390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the glucocorticoid fluticasone propionate in plasma by automated solid-phase extraction and liquid chromatography-tandem mass spectrometry.
    Callejas SL; Biddlecombe RA; Jones AE; Joyce KB; Pereira AI; Pleasance S
    J Chromatogr B Biomed Sci Appl; 1998 Nov; 718(2):243-50. PubMed ID: 9840434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of epimeric budesonide and fluticasone propionate in human plasma by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry.
    Li N; Tattam B; Brow KF; Seale JP
    J Chromatogr B Biomed Sci Appl; 2001 Sep; 761(2):177-85. PubMed ID: 11587347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive simultaneous determination of ciclesonide, ciclesonide-M1-metabolite and fluticasone propionate in human serum by HPLC-MS/MS with APPI.
    Mascher HJ; Zech K; Mascher DG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):84-92. PubMed ID: 18514597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sensitive radioimmunoassay, incorporating solid-phase extraction, for fluticasone 17-propionate in plasma.
    Bain BM; Harrison G; Jenkins KD; Pateman AJ; Shenoy EV
    J Pharm Biomed Anal; 1993 Jul; 11(7):557-61. PubMed ID: 8399529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The determination of budesonide and fluticasone in human sputum samples collected from COPD patients using LC-MS/MS.
    Buscher BA; Jägfeldt H; Sandman H; Brust-van Schaik R; van Schaik F; Brüll LP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 880(1):6-11. PubMed ID: 22169057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high-throughput liquid chromatography tandem mass spectrometry method for the comparative determination of fluticasone propionate by reversed-phase liquid chromatography and capillary electrophoresis methods in pharmaceutical nasal sprays.
    Sangoi Mda S; Wrasse M; D'Avila FB; Bernardi RM; de Oliveira PR; Dalmora SL; Bueno Rolim CM
    Eur J Mass Spectrom (Chichester); 2009; 15(6):723-30. PubMed ID: 19940338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of interaction between salmeterol and fluticasone propionate and its effect on quantitative accuracy of an LC/MS/MS assay in human plasma at low pg/mL concentrations.
    Carter SJ; Cápka V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(2):163-9. PubMed ID: 19010742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasensitive and automated 1 pg/ml fluticasone propionate assay in human plasma using LC-MS/MS.
    Ji AJ; Zhou D; Zhang S; Cawley MA; Fang X; Wu J
    Bioanalysis; 2013 Feb; 5(4):423-35. PubMed ID: 23414376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of fluticasone propionate in horse plasma and urine following inhaled administration.
    Gray BP; Biddle S; Pearce CM; Hillyer L
    Drug Test Anal; 2013 May; 5(5):306-14. PubMed ID: 22514113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid and sensitive HPLC-APCI-MS/MS method determination of fluticasone in human plasma: application for a bioequivalency study in nasal spray formulations.
    Byrro RM; César IC; de Santana e Silva Cardoso FF; Mundim IM; Teixeira Lde S; Bonfim RR; Gomes SA; Pianetti GA
    J Pharm Biomed Anal; 2012 Mar; 61():38-43. PubMed ID: 22178434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in chronic obstructive pulmonary disease.
    Singh SD; Whale C; Houghton N; Daley-Yates P; Kirby SM; Woodcock AA
    Br J Clin Pharmacol; 2003 Apr; 55(4):375-81. PubMed ID: 12680886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of fluticasone propionate in human plasma by LC-MS/MS and its application in the pharmacokinetic study of nasal spray at clinical doses.
    Yamagata A; Adachi R; Yokokawa A; Furihata T; Shibasaki H
    Drug Metab Pharmacokinet; 2024 Feb; 54():100541. PubMed ID: 38150944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler.
    Thorsson L; Edsbäcker S; Källén A; Löfdahl CG
    Br J Clin Pharmacol; 2001 Nov; 52(5):529-38. PubMed ID: 11736861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration.
    Möllmann H; Wagner M; Meibohm B; Hochhaus G; Barth J; Stöckmann R; Krieg M; Weisser H; Falcoz C; Derendorf H
    Eur J Clin Pharmacol; 1998 Feb; 53(6):459-67. PubMed ID: 9551705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid chromatography-tandem mass spectrometry analysis of urinary fluticasone propionate-17beta-carboxylic acid for monitoring compliance with inhaled-fluticasone propionate therapy.
    Korpi-Steiner NL; Netzel BC; Seegmiller JC; Hagan JB; Singh RJ
    Steroids; 2010 Jan; 75(1):77-82. PubMed ID: 19883673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.